08 December 2006
Innate and Adaptive Processes in the Spleen
Anna Wluka, Waldemar L OlszewskiAnn Transplant 2006; 11(4): 22-29 :: ID: 497034
Abstract
The spleen is a lymphatic organ interposed in the blood stream. It remains a largely neglected aggregate of lymphoid tissue. The spleen immune system is responsible for protecting the body from invading pathogens and detecting senescent, mechanically damaged, displaced and aberrant cells that could lead to tumor formation. Recent studies prove its dominant role in a simultaneous dual reaction to bacterial and allogeneic antigens. Spleen is the site of innate and adaptive immune processes. Microbial penetration of tissues evokes an immediate reaction of the innate system, whereas the adaptive immune response involves the interaction of cells that recognize a particular antigen in context with MHC molecules presented by antigen-presenting cells. This review gives some insight into the immune events in the spleen and its neglected systemic role in the allogeneic reaction.
Keywords: Spleen, Innate Immunit, adaptive immunity, Bacteria, Transplantation
In Press
Original article
Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...Ann Transplant In Press; DOI: 10.12659/AOT.951568
Original article
Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.950589
Database Analysis
Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...Ann Transplant In Press; DOI: 10.12659/AOT.950289
Original article
Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...Ann Transplant In Press; DOI: 10.12659/AOT.950997
Most Viewed Current Articles
24 Aug 2021 : Review article 18,372
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
05 Apr 2022 : Original article 14,731
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 14,244
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
29 Dec 2021 : Original article 13,752
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588






